市場調查報告書

血管損傷治療的市場規模(2020年∼2027年)

Global Vascular Injury Treatment Market - 2020-2027

出版商 DataM Intelligence 商品編碼 955334
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
血管損傷治療的市場規模(2020年∼2027年) Global Vascular Injury Treatment Market - 2020-2027
出版日期: 2020年08月27日內容資訊: 英文
簡介

血管損傷治療的市場規模的成長,主要由於事故,跌倒,刀傷,骨脫位造成的血管損傷的增加所促進。在該市場中,Massachusetts General Hospital,Cleveland Clinic,Heidelberg University Hospital,Mayo Clinic Health System,Universal Health Services Inc.,IHH Healthcare Berhad,Apollo Hospitals Enterprise Ltd.,Royal Berkshire NHS Foundation Trust,Mediclinic International,Tenet Healthcare等數家公司是對成長有貢獻的主要企業。主要製造商,根據擴大血管損傷治療的生產能力,在全球強化其存在。還有主要企業,採用產品的銷售、收購、合作等幾個成長策略,推動全球市場成長。

本報告提供全球血管損傷治療市場的相關調查,市場機會,成長及阻礙因素,各治療類型、損傷、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 市場調查手法和範圍

第2章 市場定義和概要

第3章 摘要整理

  • 各治療類型
  • 各損傷
  • 各終端用戶
  • 各地區

第4章 市場動態

  • 影響市場的要素
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 技術的進步
  • 價格分析
  • 法規分析
  • 潛在的需求

第6章 市場分析:各治療類型

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析
  • 市場魅力指數
    • 側道移植*
    • 貼片血管成形術
    • 解剖學的側道
    • 側方後鼻子/腹側鼻
    • 血栓切除
    • 其他

第7章 市場分析:各損傷

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析
  • 市場魅力指數
    • 裂傷/斷開
    • 血栓症
    • 痙攣
    • 挫傷/內膜瓣
    • 動靜脈(AV)瘺
    • 動脈瘤和假動脈瘤
    • 其他

第8章 市場分析:各終端用戶

  • 簡介
  • 市場規模分析,及與前一年同期比較成長分析
  • 市場魅力指數
    • 醫院
    • 門診病人手術中心
    • 其他

第7章 市場分析:各地區

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析
    • 市場魅力指數
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東、非洲

第8章 競爭情形

  • 競爭模式
  • 市場地位/佔有率分析
  • 合併和收購分析

第11章 企業簡介

  • Massachusetts General Hospital
  • Cleveland Clinic
  • Heidelberg University Hospital
  • Mayo Clinic Health System
  • Universal Health Services,Inc.
  • IHH Healthcare Berhad
  • Apollo Hospitals Enterprise Ltd.
  • Royal Berkshire NHS Foundation Trust
  • Mediclinic International
  • Tenet Healthcare

第10章 重要考察

第11章 DataM

目錄

Market Overview

Vascular surgery is intervention of venous, lymphatic systems, and arterial conditions of diagnosed patients. Vascular surgery is mainly done for patients suffering from some common vascular diseases, such as varicose veins, lymphatic conditions, thoracic outlet syndrome, intermittent claudication, artery malformations, hyperhidrosis, and others. Trauma caused due to the pelvis, abdomen, and retroperitoneal structures of the body is the most challenging vascular injuries. Some of the complications such as difficulty in acquiring immediate proximal control & appropriate exposure, treatment of injury in the face of contamination, and provisions for prolonged surveillance & follow-up have increased the need for vascular injury treatment. Healthcare providers in the vascular injury treatment are increasingly adopting the extra-anatomical aortic bypass graft to solve grave vascular injuries in military and emergency cases.

The global vascular injury treatment market size was worth US$ XX billion in 2018 and is estimated to reach US$ XX billion by 2027, growing at a CAGR of XX % during the forecast period (2020-2027).

Market Dynamics

The global vascular injury treatment market growth is majorly driven by the rising prevalence of vascular injuries, owing to accidents, falls, cuts, and dislocation of bones. As per the National Trauma Databank, vascular injuries hold for 1% to 2% of all the injuries in trauma patients. Penetrating trauma is one of the leading cause of peripheral vascular injuries, which accounts for over 75% of all vascular injuries in 2019. Handguns are among the major cause of penetrating injuries among penetrating vascular injuries in the United States. According to the data published in the Journal of Evolution of Medical and Dental Science, the prevalence of vascular trauma has increased over past few years, and vascular injuries account nearly 3% of all civilian trauma cases. Thus, trauma is considered to be a leading cause of vascular injury. Also, as per the Journal of Emergency and Critical Care Medicine, the annual death toll due to trauma has reached over 400,000 in China, which ranks it the fifth most common cause of death. The economic development is also leading to an increase in the number of road accidents, which is currently the most common cause of trauma.

In the United States, less than 80% of cases of vascular injury is caused by penetrating trauma, which is due to increasing usage of endovascular interventions for medical and diagnostic purposes. About 30% of vascular casualties are minimal-energy injuries, whereas high-energy injuries account for over 52% of the vascular injuries.

The rising number of injuries owing to sports injuries is further driving the market for the treatment of vascular injury. For instance, according to the CDC (Centers for Disease Control and Prevention), the high school athletes account for 2 million incidents, 50,000 visits to the doctor, and 30,000 hospital admissions in the U.S. each year.

In addition, technological advancements in endovascular techniques, magnetic resonance imagining (MRI), and CT angiography is helping by detecting vascular injuries through high sensitivity and specificity.

However, high cost is a major factor influencing the selection of treatment of the vascular injury. Obesity and morbidity increase the risk of vascular injuries which require a longer stay in hospitals, which leads to the high hospitals care cost. The cost of hospitalization for vascular injuries is comparatively higher with non-vascular injuries. For example, the cost of hospitalization for vascular injuries costs over US$ 135,500, and that of non-vascular injuries is US$ 65,000. Hence, the high cost of treatment is likely to restrain the growth of the global vascular injury treatment market.

Segment Analysis

The global vascular injury treatment market is segmented by treatment type into bypass graft, patch angioplasty, extra-anatomic bypass, lateral arteriorrhaphy/ venorrhaphy, thrombectomy, and others. Among these, the bypass graft segment is dominating the vascular injury treatment market in 2019, owing to rising incidence rates and increasing health complications associated with several vascular diseases. Some of the severe vascular disorders such as peripheral artery disease (PAD), stroke, carotid artery disease (CAD), arteriovenous malformation (AVM), pulmonary embolism, abdominal aortic aneurysm (AAA), deep vein thrombosis (DVT), critical limb ischemia (CLI), chronic venous insufficiency (CVI), and varicose veins are increasing the demand for the treatment of these disorders. According to the National Institutes of Health (NIH), around 14 million men and women are affected by coronary heart disease in the United States. It is one of the most disorder in the elderly population over 65 years old. It is caused by a waxy substance called a plaque which accumulates blood to the heart muscle in the arteries. In this, the bypass graft is the most common treatment for vascular injury to improve the poor flow of blood to the heart. This treatment reduces the risk of severe complications for individuals with obstructive coronary artery disease, a form of heart disease ischemic. Hence, the demand for bypass graft is increasing and is expected to drive the growth off market over the forecast period.

Geographical Analysis

North America region is dominating the global vascular injury treatment market accounting for the largest market share in 2019, due to the rising incidence of vascular diseases and growing elderly population which is expected to create large number of opportunities for the vascular injury treatment market in the region. According to the Center for Diseases Control and Prevention (CDC), in United States, about 8.5 million people suffer from peripheral artery diseases, which accounts 12%-20% of individuals older than age 60. In addition, well-established healthcare infrastructure and technological advancements propel the vascular injury treatment market in this region.

On the other hand, the vascular injury treatment market in the Asia-Pacific is expected to grow at a significant CAGR over the forecast period, owing to increasing incidence of vascular injuries and rising government initiatives in the healthcare sector. For instnace, in 2017, according to the Ministry of Road Transport & Highways, India, a total of 464,910 road accidents were reported by the States and Union Territories (UTs), claiming 147,913 lives and causing injuries to 470,975 persons. A large number of traumatic injuries leading to vascular damage contribute to the growth of the vascular injury treatment market.

Competitive Landscape

The Vascular Injury Treatment market is moderately competitive and consists of several major players. Some of the key players which are contributing to the growth of the market are Massachusetts General Hospital, Cleveland Clinic, Heidelberg University Hospital, Mayo Clinic Health System, Universal Health Services, Inc., IHH Healthcare Berhad, Apollo Hospitals Enterprise Ltd., Royal Berkshire NHS Foundation Trust, Mediclinic International, Tenet Healthcare, among others. The major manufacturers are strengthening their presence globally by expanding their production capacities in the vascular injury treatment.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the vascular injury treatment market globally. For instance,

  • In April 2019, Mayo Clinic has collaborated with the Children's Hospital Colorado to find a solution for hypoplastic left heart syndrome.
  • In 2018, the Universal Health Services has acquired the Danshell Group, which includes 25 behavioral health facilities in the U.K. Also, the company has acquired a 109-bed behavioral healthcare facility located in Gulfport, Mississippi.
  • In October 2018, Eko collaborated with Mayo Clinic to develop data-driven technology which helps detect heart diseases.
  • In September 2018, the Hirslanden Clinique La Colline, a part of Mediclinic International, and Clinique Des Grangettes had merged to provide a comprehensive range of therapeutic & diagnostic services for patients.
  • In August 2015, Apollo Hospitals collaborated with the American College of Cardiology (ACC) to expand medical education in India.

Why Purchase the Report?

  • Visualize the composition of the vascular injury treatment market segmentation by treatment type, injury, and end-user highlighting the key commercial assets and players.
  • Identify commercial opportunities in vascular injury treatment market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of vascular injury treatment market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global vascular injury treatment market report would provide an access to an approx. 61 market data table, 59 figures and 290 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Vascular Injury Treatment market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Vascular Injury Treatment market - Market Definition and Overview

3. Global Vascular Injury Treatment market - Executive Summary

  • 3.1. Market Snippet by Treatment Type
  • 3.2. Market snippet by Injury
  • 3.3. Market snippet by End-User
  • 3.4. Market Snippet by Region

4. Global Vascular Injury Treatment market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing number of vascular injury surgeries
      • 4.1.1.2. Technological advancements in treatment
      • 4.1.1.3. XX
    • 4.1.2. Restraints:
      • 4.1.2.1. Side-effects caused by vascular injury treatment
      • 4.1.2.2. XX
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Vascular Injury Treatment market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Technological Advancements
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Unmet Needs

6. Global Vascular Injury Treatment market - By Treatment Type

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type Segment
  • 6.3. Market Attractiveness Index, By Treatment Type Segment
    • 6.3.1. Bypass Graft*
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 6.3.2. Patch Angioplasty
    • 6.3.3. Extraanatomic Bypass
    • 6.3.4. Lateral Arteriorrhaphy/ Venorrhaphy
    • 6.3.5. Thrombectomy
    • 6.3.6. Others

7. Global Vascular Injury Treatment market - By Injury

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury Segment
  • 7.3. Market Attractiveness Index, By Injury Segment
    • 7.3.1. Laceration/Transection*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Thrombosis
    • 7.3.3. Spasm
    • 7.3.4. Contusion/Intimal Flap
    • 7.3.5. Arteriovenous (AV) Fistula
    • 7.3.6. Aneurysm and Pseudoaneurysm
    • 7.3.7. Others

8. Global Vascular Injury Treatment market - By End-Users

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users Segment
  • 8.3. Market Attractiveness Index, By End-Users Segment
    • 8.3.1. Hospitals*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Others

9. Global Vascular Injury Treatment market - By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

10. Global Vascular Injury Treatment market - Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Global Vascular Injury Treatment market- Company Profiles

  • 11.1. Massachusetts General Hospital*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Cleveland Clinic
  • 11.3. Heidelberg University Hospital
  • 11.4. Mayo Clinic Health System
  • 11.5. Universal Health Services, Inc.
  • 11.6. IHH Healthcare Berhad
  • 11.7. Apollo Hospitals Enterprise Ltd.
  • 11.8. Royal Berkshire NHS Foundation Trust
  • 11.9. Mediclinic International
  • 11.10. Tenet Healthcare

LIST NOT EXHAUSTIVE

12. Global Vascular Injury Treatment market - Premium Insights

13. Global Vascular Injury Treatment market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us